Enhanced Games Releases Substance Use Data Ahead of Las Vegas Event

Enhanced Games released substance usage data from its IRB-approved clinical trial ahead of the organization's first competition. The study, titled ASCEND001, found that 91 percent of athletes used testosterone, 79 percent used human growth hormone, and 62 percent used stimulants such as Adderall.

Fifty percent used metabolic modulators, 41 percent used EPO, 29 percent used anabolic steroids, and 5 percent used hormonal support therapies.

The inaugural event is scheduled for May 24 at Resorts World Las Vegas. The organization stated that the trial data is now publicly available. The data covers athletes participating in the competition, which will feature events at the Las Vegas venue.